Status:
COMPLETED
The Memory and Cognitive Performance Study
Lead Sponsor:
Vita Naturel, LLC
Collaborating Sponsors:
University of North Carolina at Asheville
Braini LLC
Conditions:
Cognitive Function
Memory
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The primary purpose of this study is to evaluate the impact of a novel, neuro-protective and neuro-restorative dietary supplement (Braini®) on standardized memory and cognitive performance parameters....
Detailed Description
The number of people affected by cognitive decline continues to rise as the US population ages. A recent report indicates that this decline can be seen as early as age 45. Optimizing cognitive functio...
Eligibility Criteria
Inclusion
- 18-30 or 55-80 years of age
- Agree to continue with current diet and refrain from taking any new nutritional or herbal supplements
- Willing to participate in the trial for 30-35 days, including taking a placebo
- Able to understand and write English
Exclusion
- Clinically diagnosed with Alzheimer's disease, stroke, Parkinson's disease, or dementia
- Taking prescription drugs to support memory/prevent cognitive decline in the past 180 days or to treat other diseases referenced below in criterion number.
- Taking dietary supplements that include wild blueberry extract, Neurxcel, or silk portein peptide in the past 90 days
- Active fibromyalgia, multiple sclerosis, seizures/epilepsy or other known diseases that affect memory or cognition
- Taking an medicines that are stimulants including Adderall XR (amphetamine), Concerta (methylphenidate), Dexedrine (amphetamine), Evekeo (amphetamine), Focalin XR (methylphenidate), Quillivant XR (methylphenidate), Ritalin (methylphenidate), Strattera (atomoxetine hydrochloride), or Vyvanse (lisdexamfetamine dimesylate).
- GI disorders known to impair absorption of nutrients
- Traumatic brain injury (TBI) in personal history
- MOCA test score \<21
- Pregnancy
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04025255
Start Date
October 1 2019
End Date
April 30 2020
Last Update
November 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Asheville
Asheville, North Carolina, United States, 28804